Key Insights

Highlights

Success Rate

80% trial completion

Published Results

24 trials with published results (20%)

Research Maturity

59 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

12.2%

15 terminated out of 123 trials

Success Rate

79.7%

-6.8% vs benchmark

Late-Stage Pipeline

10%

12 trials in Phase 3/4

Results Transparency

41%

24 of 59 completed with results

Key Signals

24 with results80% success15 terminated

Data Visualizations

Phase Distribution

86Total
Not Applicable (53)
Early P 1 (2)
P 1 (6)
P 2 (13)
P 3 (9)
P 4 (3)

Trial Status

Completed59
Recruiting19
Terminated15
Unknown12
Active Not Recruiting5
Withdrawn4

Trial Success Rate

79.7%

Benchmark: 86.5%

Based on 59 completed trials

Clinical Trials (123)

Showing 20 of 20 trials
NCT05691738Not ApplicableCompleted

Effects of Modified Otago Exercises in Individuals With Diabetic Neuropathy

NCT04650178Active Not Recruiting

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

NCT07095998Not ApplicableRecruiting

Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

NCT07227909Phase 2Not Yet Recruiting

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

NCT01864460Not ApplicableCompleted

Improving Autonomic Function and Balance in Diabetic Neuropathy

NCT02610439Recruiting

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer

NCT05041387RecruitingPrimary

Data Collection of Standard Care of Patients in the EMG Section

NCT07137078Not ApplicableCompletedPrimary

Pilates Versus Gyrotonic Expansion System on Chemotherapy Induced Peripheral Neuropathy and Fall Risk

NCT07437989RecruitingPrimary

Collection of Demographic, Clinical, and Instrumental Data of Patients With Peripheral Neuropathy Including Neurological Examination Data, Peripheral Nerve Conduction Analysis, and Nerve Electromyography and Ultrasound).

NCT06837181Recruiting

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

NCT04207437Not ApplicableRecruitingPrimary

Daily Hand-Held Vibration Therapy

NCT05121558Not ApplicableActive Not Recruiting

The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)

NCT07390279Recruiting

Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia

NCT07390617RecruitingPrimary

A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

NCT04687215Recruiting

Diabetic Neuropathy in Spinal Cord Stimulator Patients

NCT04917796Not ApplicableActive Not Recruiting

The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)

NCT06807294Not ApplicableRecruiting

Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

NCT05758753Not ApplicableSuspended

QST for Corneal Nerve Function

NCT07022938Phase 4Completed

Nutritional Supplement for Treating Chemotherapy Induced Neuropathy

NCT07287592Phase 3Not Yet RecruitingPrimary

Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.

Scroll to load more

Research Network

Activity Timeline